Drug Pipeline

Dotarem Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
6
Active Studies
4
Recruiting
1
Phase 3
4
Top Sponsors
Active Studies by Phase
Phase 4
1
Phase 3
1
Phase 2
3
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT04373564 Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based… Motor Function Recruiting
Phase 3
NCT07348640 Evaluation of the Efficacy and Safety of Magnetic Resonance Angiography (MRA) Using… Steno-occlusive Disease Not Yet Recruiting
Phase 2
NCT05417776 Collagen-targeted PET Imaging for Early Interstitial Lung Disease Interstitial Lung Disease Recruiting
NCT06532071 Advanced Imaging for Pulmonary Fibrosis Pulmonary Fibrosis Recruiting
NCT07572383 Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis Interstitial Lung Disease Recruiting
Phase 1
NCT06600880 Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its… Alzheimer Disease, Early Onset Not Yet Recruiting
Sponsors Running Dotarem Trials
Guerbet (2) Peter Caravan (2) Massachusetts General Hospital (1) Columbia University (1)
Disease Areas
Idiopathic Pulmonary Fibrosis (2) Alzheimer's Disease (1)
Get alerts when Dotarem trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free